📰 Biologic First News
Biologic First News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biologic First. Real-time updates on events, politics, business and more.
April 1, 2024
The findings have implications for insurance rules that require patients to take a DMARD for a minimum period before initiating biologic therapy.
November 14, 2022
A total of 297 patients with pediatric juvenile idiopathic arthritis who had a 3-year visit, were included in the study.
November 3, 2021
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.